ChatGPT is Poised to Disrupt Medical Affairs
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
This author has not written his bio yet.
But we are proud to say that Medical Affairs contributed 332 entries already.
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
Library of video interviews with Medical Affairs leaders discussing the future of the function, building Medical from scratch, the Medical professional, and much more.
Medical Affairs teams are innovating their approach to engaging patients and empowering people to manage their chronic health conditions. Here, we explore one case study of people living with hidradenitis suppurativa.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
MAPS speaks with Eric Peacock, co-Founder and CEO of MyHealthTeam, about the alignment between social justice and business best-practices to promote health equity using patient communities.
This Altmetric White Paper explores how to measure the value of Medical Affairs publications beyond counting citations.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
In Q&A format, this article summarizes key learnings from a MAPS 2022 Global Annual Meeting panel presented by the Medical Strategy FAWG.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.